AbbVie has tremendous experience in immunology with a quarter-century of raising the bar to treat immune-mediated diseases. This podcast series shares discussions with AbbVie experts about the future of immunology, prioritizing patient needs, access to care and research.
Hosted by Adrian Louzao-Pino, Head of Immunology, this four-part podcast series explores the interconnected efforts helping shape the future of immunology care in Canada.
In this episode, Sadri Osmane, Head of Business Technology Solutions, discusses how emerging technologies, data, and artificial intelligence are shaping the future of immunology and how these advances have the potential to improve the experience of people living with immune-mediated diseases.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.